Back to mobile site

Axsome Therapeutics (AXSM) PT Raised to $196 at Morgan Stanley

November 4, 2025 9:08 AM EST
Get Alerts AXSM Hot Sheet
Price: $213.67 --0%

Rating Summary:
    26 Buy, 1 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Morgan Stanley analyst Sean Laaman raised the price target on Axsome Therapeutics (NASDAQ: AXSM) to $196.00 (from $194.00) while maintaining a Overweight rating.

You May Also Be Interested In





Related Categories

Analyst PT Change